272 related articles for article (PubMed ID: 27429984)
41. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
[TBL] [Abstract][Full Text] [Related]
42. Cancer diagnosis in a cohort of patients with Sjogren's syndrome and rheumatoid arthritis: a single-center experience and review of the literature.
Boussios S; Pentheroudakis G; Somarakis G; Markatseli TE; Drosos AA; Pavlidis N
Anticancer Res; 2014 Nov; 34(11):6669-76. PubMed ID: 25368273
[TBL] [Abstract][Full Text] [Related]
43. Hematologic manifestations of connective autoimmune diseases.
Fietta P; Delsante G; Quaini F
Clin Exp Rheumatol; 2009; 27(1):140-54. PubMed ID: 19327244
[TBL] [Abstract][Full Text] [Related]
44. Sjögren Syndrome-associated lymphomas: an update on pathogenesis and management.
Nocturne G; Mariette X
Br J Haematol; 2015 Feb; 168(3):317-27. PubMed ID: 25316606
[TBL] [Abstract][Full Text] [Related]
45. Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions.
Hemminki K; Li X; Sundquist J; Sundquist K
Arthritis Rheum; 2009 Mar; 60(3):661-8. PubMed ID: 19248111
[TBL] [Abstract][Full Text] [Related]
46. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
Ebo D; DeClerck LS; Bridts CH; Stevens WJ
In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
[TBL] [Abstract][Full Text] [Related]
47. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
Yang Z; Ren Y; Liu D; Lin F; Liang Y
APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
[TBL] [Abstract][Full Text] [Related]
48. Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case-control study.
Hellgren K; Iliadou A; Rosenquist R; Feltelius N; Backlin C; Enblad G; Askling J; Baecklund E
Ann Rheum Dis; 2010 Apr; 69(4):654-9. PubMed ID: 19439429
[TBL] [Abstract][Full Text] [Related]
49. [Lymphoproliferative disease in patients with autoimmune and inflammatory diseases: significance of antigenic stimulation and inflammatory processes].
Tvarůzková Z; Pavlová S; Doubek M; Mayer J; Pospísilová S
Cas Lek Cesk; 2011; 150(3):161-8. PubMed ID: 21560455
[TBL] [Abstract][Full Text] [Related]
50. Sjögren's syndrome in relation to other autoimmune diseases.
Feltkamp TE
Neth J Med; 1992 Apr; 40(3-4):105-7. PubMed ID: 1603198
[TBL] [Abstract][Full Text] [Related]
51. BAFF overexpression is associated with autoantibody production in autoimmune diseases.
Pers JO; Daridon C; Devauchelle V; Jousse S; Saraux A; Jamin C; Youinou P
Ann N Y Acad Sci; 2005 Jun; 1050():34-9. PubMed ID: 16014518
[TBL] [Abstract][Full Text] [Related]
52. Malignant neoplasms in autoimmune rheumatic diseases: examination of the risk of developing a malignancy among five different rheumatic diseases in one institution.
Villa AR; Kraus A; Jiménez-Corona A; Sandino S; Velázquez-González A; Granados J; Alarcón-Segovia D
J Clin Rheumatol; 2000 Aug; 6(4):176-83. PubMed ID: 19078467
[TBL] [Abstract][Full Text] [Related]
53. Clinical characteristics of patients with lymphoproliferative neoplasms in the setting of systemic autoimmune diseases.
Suvajdzic N; Djurdjevic P; Todorovic M; Perunicic M; Stojanović R; Novkovic A; Mihaljevic B
Med Oncol; 2012 Sep; 29(3):2207-11. PubMed ID: 21755372
[TBL] [Abstract][Full Text] [Related]
54. [Biological therapy of arthritis and systemic autoimmune diseases].
Tamási L; Szekanecz Z
Orv Hetil; 2007 Apr; 148 Suppl 1():63-70. PubMed ID: 17430797
[TBL] [Abstract][Full Text] [Related]
55. Chronic widespread pain in the spectrum of rheumatological diseases.
Atzeni F; Cazzola M; Benucci M; Di Franco M; Salaffi F; Sarzi-Puttini P
Best Pract Res Clin Rheumatol; 2011 Apr; 25(2):165-71. PubMed ID: 22094193
[TBL] [Abstract][Full Text] [Related]
56. Malignancies in autoimmune rheumatic diseases - a mini-review.
Szekanecz Z; Szekanecz E; Bakó G; Shoenfeld Y
Gerontology; 2011; 57(1):3-10. PubMed ID: 20453490
[TBL] [Abstract][Full Text] [Related]
57. [Autoimmune diseases and cancers. Part I: cancers complicating autoimmune diseases and their treatment].
Pasquet F; Pavic M; Ninet J; Hot A
Rev Med Interne; 2014 May; 35(5):310-6. PubMed ID: 24268698
[TBL] [Abstract][Full Text] [Related]
58. Autoimmune disease aggregation in families with primary Sjögren's syndrome.
Anaya JM; Tobon GJ; Vega P; Castiblanco J
J Rheumatol; 2006 Nov; 33(11):2227-34. PubMed ID: 17086607
[TBL] [Abstract][Full Text] [Related]
59. Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma.
Baecklund E; Sundström C; Ekbom A; Catrina AI; Biberfeld P; Feltelius N; Klareskog L
Arthritis Rheum; 2003 Jun; 48(6):1543-50. PubMed ID: 12794821
[TBL] [Abstract][Full Text] [Related]
60. Adjuvants and lymphoma risk as part of the ASIA spectrum.
Butnaru D; Shoenfeld Y
Immunol Res; 2015 Feb; 61(1-2):79-89. PubMed ID: 25582758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
